Riskpilot← Back to searchSign inGet full accessDANTRIALS ApS
APSActiveCVR 32158234Nielsine Nielsens Vej 6BResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20092 employeeswww.dantrials.com
Revenue 2024
DKK -329K
-108% vs 2023
EBITDA margin
136.5%
-236% vs 2023
Equity ratio
68.1%
Financial strength
Net profit 2024
DKK -344K
-232% vs 2023
| Revenue | DKK -329K | -108% |
| EBITDA | DKK -449K | -236% |
| Net profit | DKK -344K | -232% |
| Total assets | DKK 2,2M | -70% |
| Equity | DKK 1,5M | -19% |
| Employees | 2 | — |
Legal name
DANTRIALS ApS
CVR number
32158234
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
26. maj 2009
Share capital
DKK 125.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør.
Company purpose
Selskabets formål er at udføre og assistere med planlægning, gennemførelse og afrapportering af kliniske afprøvninger og relaterede opgaver som kontraktforskning samt at yde konsulentbistand.
Address
Nielsine Nielsens Vej 6B
Phone
+4531352683
Email
info@dantrials.com
Website
www.dantrials.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.003 | 1.223 | 3.437 | 7.349 | 4.966 | 4.587 | 6.374 | 2.976 | 2.333 | 3.851 | 7.014 | 4.028 | -329 |
| Staff expenses | -1.398 | -953 | -2.444 | -5.342 | -4.257 | -4.092 | -4.551 | -2.861 | -2.197 | -3.645 | -6.378 | -3.699 | -120 |
| EBITDA | 84 | 269 | 993 | 2.007 | 709 | 495 | 1.823 | 115 | 137 | 201 | 636 | 329 | -449 |
| Depreciation & amort. | -30 | -32 | -33 | -52 | -60 | -24 | -26 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 55 | 237 | 960 | 1.955 | 648 | 471 | 1.797 | 115 | 137 | 201 | 636 | 329 | -449 |
| Net financials | 2 | -1 | -12 | -17 | -82 | -19 | 19 | 19 | -1 | -16 | -6 | 6 | 11 |
| Profit before tax | 57 | 237 | 948 | 1.939 | 567 | 452 | 1.816 | 134 | 136 | 186 | 630 | 335 | -437 |
| Tax | 16 | 59 | 260 | 483 | 125 | 106 | 1.428 | -0 | -152 | -201 | 138 | 74 | -93 |
| Net profit | 41 | 178 | 688 | 1.456 | 442 | 346 | 388 | 134 | 287 | 386 | 492 | 260 | -344 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 788 | 1.511 | 5.562 | 13.065 | 12.682 | 10.619 | 9.751 | 6.239 | 5.961 | 6.479 | 8.531 | 7.480 | 2.213 |
| Equity | 482 | 660 | 1.348 | 2.804 | 2.245 | 2.150 | 2.192 | 2.126 | 713 | 1.100 | 1.591 | 1.852 | 1.507 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 75 | 0 | 138 | 74 | 0 |
| Short-term debt | 294 | 843 | 4.214 | 10.262 | 10.436 | 8.470 | 7.559 | 4.098 | 5.172 | 5.379 | 6.801 | 5.554 | 705 |
| Total debt | 294 | 843 | 4.214 | 10.262 | 10.436 | 8.470 | 7.559 | 4.113 | 5.248 | 5.379 | 6.939 | 5.629 | 705 |
EBITDA margin
-44857800.0%
This company
15.8%
Market median
-283910227% vs market
20122024
Equity ratio
68.1%
This company
38.2%
Market median
+78% vs market
20122024
Return on equity
-22.9%
This company
18.4%
Market median
-224% vs market
20122024
Net profit margin
-34449900.0%
This company
8.1%
Market median
-425307507% vs market
20122024
Asset turnover
-0.15×
This company
1.12×
Market median
-113% vs market
20122024
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TB Chief Executive Officer | Chief Executive Officer | 2009 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2009 | — | — | |
| Chairman | 2009 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
DANTRIALS HOLDING ApS | Company | 100.0% | 100.0% | 2009 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
DANTRIALS HOLDING ApS
DANTRIALS ApS Board members of DANTRIALS ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Torben Balchen | Chief Executive Officer | 0 companies |
| Carsten Sennov | Board of Directors | 0 companies |
| Benny Kim Hofmann | Chairman | 0 companies |